DeLuca · Nucleic acids research 2026 · informatics resource development · n=?

Medicines, Diseases, Indications, and Contraindications (MeDIC): a foundational resource to support drug repurposing.

Cited 0 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Database and informatics resource development (by design analogy, not clinical CEBM)

PubMed 41385096 · doi:10.1093/nar/gkaf1312 · record verified 2026-08-26

What was done

The authors developed Medicines, Diseases, Indications, and Contraindications (MeDIC), an open-access database built exclusively from government regulatory sources to support drug repurposing. MeDIC compiles curated entries of drugs (including combination therapies), diseases, indications, and contraindications, mapping each entity to multiple biomedical ontologies in a tabular, machine learning-compatible format.

What was found

The abstract reports the design, public accessibility via a web interface (https://medic.renci.org), and downloadable open-source code. The abstract gives no numbers regarding the total counts of drugs, diseases, indications, or ontology mappings.

Why it matters

By relying solely on official regulatory sources and standardized ontologies, MeDIC provides a curated foundation for biomedical knowledge graphs aimed at generating high-confidence drug repurposing hypotheses.

Limits

The abstract provides no quantitative validation metrics, entity counts, update frequency details, or benchmark comparisons against existing biomedical databases. As an informatics resource, it does not provide clinical or experimental validation of repurposing targets.

Cited by